The grades of seven Medical Devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This week, NuVasive (NASDAQ:NUVA) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). Nuvasive designs, develops, and markets products for the surgical treatment of spine disorders. In Portfolio Grader’s specific subcategory of Earnings Momentum, NUVA also gets an A. Shares of NUVA have increased 8.7% over the past month, better than the 1.6% increase the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of NUVA stock.
This week, Covidien (NYSE:COV) pushes up from a C to a B rating. Covidien is engaged in the development, manufacture, and sale of healthcare products, including pharmaceuticals and medical supplies, for use in clinical and home settings. Wall Street seems to agree with the upgrade and has propelled the stock up 6% over the past month. For more information, get Portfolio Grader’s complete analysis of COV stock.
This week, China Kanghui (NYSE:KH) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). China Kanghui produces trauma supplies including nails, plates and screws, and cranial maxillofacial plate and screw systems, and spinal products including screws, meshes, interbody cages, and fixation systems. For more information, get Portfolio Grader’s complete analysis of KH stock.
Vascular Solutions (NASDAQ:VASC) is seeing ratings go up from a C last week to a B this week. Vascular Solutions is a medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide. Investors seem to agree with the upgraded status of the stock, and have pushed the stock up 12.9% over the past month. For more information, get Portfolio Grader’s complete analysis of VASC stock.
This is a strong week for Trinity Biotech (NASDAQ:TRIB). The company’s rating climbs to A from the previous week’s B. Trinity Biotech develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. For more information, get Portfolio Grader’s complete analysis of TRIB stock.
Symmetry Medical (NYSE:SMA) boosts its rating from a C to a B this week. Symmetry Medical provides global orthopedic device manufacturers with implants and related instruments and cases. Wall Street has pushed the stock higher by 6.2% over the past month. For more information, get Portfolio Grader’s complete analysis of SMA stock.
CryoLife (NYSE:CRY) improves from a C to a B rating this week. CryoLife preserves and distributes human tissues in addition to developing, manufacturing, and commercializing medical devices for cardiac and vascular transplant applications. Investors have pushed the stock price up 24.4% over the past month. For more information, get Portfolio Grader’s complete analysis of CRY stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.